{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T11:54:59Z","timestamp":1781524499539,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.josat.2026.209997","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:21:53Z","timestamp":1777011713000},"page":"209997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Stimulant use and increased severity of opioid use disorder and mental illness in patients with co-occurring disorders"],"prefix":"10.1016","volume":"188","author":[{"given":"Mariah M.","family":"Kalmin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Crowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Bilder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen M.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Weir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth Ann","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Komaromy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2026.209997_bb0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.drugalcdep.2019.03.014","article-title":"Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths","volume":"200","author":"Barocas","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2026.209997_bb0010","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"Journal of the Royal Statistical Society. Series B (Methodological)"},{"issue":"6","key":"10.1016\/j.josat.2026.209997_bb0015","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/jts.22059","article-title":"The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): Development and initial psychometric evaluation","volume":"28","author":"Blevins","year":"2015","journal-title":"Journal of Traumatic Stress"},{"issue":"4","key":"10.1016\/j.josat.2026.209997_bb0020","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Current Opinion in Psychiatry"},{"issue":"1","key":"10.1016\/j.josat.2026.209997_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13722-023-00364-3","article-title":"Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations","volume":"18","author":"Cook","year":"2023","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.josat.2026.209997_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173495","article-title":"Substance use disorders and social determinants of health from electronic medical records obtained during Kentucky\u2019s \u201ctriple wave\u201d","volume":"221","author":"Delcher","year":"2022","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.josat.2026.209997_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2016.08.006","article-title":"Opioid overdose experience, risk behaviors, and knowledge in drug users from a rural versus an urban setting","volume":"71","author":"Dunn","year":"2016","journal-title":"Journal of Substance Use and Addiction Treatment"},{"issue":"1","key":"10.1016\/j.josat.2026.209997_bb0040","first-page":"110","article-title":"The Posttraumatic Stress Disorder (PTSD) Checklist for DSM-5: A systematic review of existing psychometric evidence","volume":"30","author":"Forkus","year":"2023","journal-title":"Clinical Psychology (New York)"},{"issue":"1","key":"10.1016\/j.josat.2026.209997_bb0045","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13722-021-00266-2","article-title":"The impact of methamphetamine\/amphetamine use on receipt and outcomes of medications for opioid use disorder: A systematic review","volume":"16","author":"Frost","year":"2021","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.josat.2026.209997_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.112455","article-title":"Housing instability increases for stimulant-involved overdose deaths after linking surveillance data to electronic health records in Kentucky","volume":"264","author":"Harris","year":"2024","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.josat.2026.209997_bb0055","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/MLR.0000000000001460","article-title":"Service involvement across multiple sectors among people who use opioids, methamphetamine, or both, United States-2015-2018","volume":"59","author":"Howell","year":"2021","journal-title":"Medical Care"},{"key":"10.1016\/j.josat.2026.209997_bb0060","series-title":"Monitoring the Future: National Survey Results on Drug Use, 1975-2002. Volume I: Secondary School Students","author":"Johnston","year":"2003"},{"key":"10.1016\/j.josat.2026.209997_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2023.208986","article-title":"Daily opioid and stimulant co-use and nonfatal overdoses in the context of social disadvantage: Findings on marginalized populations","volume":"151","author":"Jones","year":"2023","journal-title":"Journal of Substance Use and Addiction Treatment"},{"issue":"1","key":"10.1016\/j.josat.2026.209997_bb0070","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/epirev\/mxaa011","article-title":"The evolving overdose epidemic: Synthetic opioids and rising stimulant-related harms","volume":"42","author":"Jones","year":"2020","journal-title":"Epidemiologic Reviews"},{"issue":"2","key":"10.1016\/j.josat.2026.209997_bb0075","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/add.14812","article-title":"Increases in methamphetamine use among heroin treatment admissions in the United States, 2008-17","volume":"115","author":"Jones","year":"2020","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.josat.2026.209997_bb0080","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.26544","article-title":"Association of methamphetamine and opioid use with nonfatal overdose in rural communities","volume":"5","author":"Korthuis","year":"2022","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2026.209997_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2022.208934","article-title":"Methamphetamine use and illicit opioid use during buprenorphine treatment","author":"Kratina-Hathaway","year":"2023","journal-title":"Journal Substance Use and Addiction Treatment"},{"key":"10.1016\/j.josat.2026.209997_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2021.106354","article-title":"Design of CLARO (Collaboration Leading to Addiction Treatment and Recovery from other Stresses): A randomized trial of collaborative care for opioid use disorder and co-occurring depression and\/or posttraumatic stress disorder","volume":"104","author":"Meredith","year":"2021","journal-title":"Contemporary Clinical Trials"},{"issue":"4","key":"10.1016\/j.josat.2026.209997_bb0095","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/00952990.2022.2081923","article-title":"Trends in characteristics of fentanyl-related poisonings in the United States, 2015-2021","volume":"48","author":"Palamar","year":"2022","journal-title":"American Journal of Drug Alcohol Abuse"},{"key":"10.1016\/j.josat.2026.209997_bb0100","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.drugalcdep.2015.09.008","article-title":"Item banks for substance use from the Patient-Reported Outcomes Measurement Information System (PROMIS((R))): Severity of use and positive appeal of use","volume":"156","author":"Pilkonis","year":"2015","journal-title":"Drug Alcohol Dependence"},{"issue":"12","key":"10.1016\/j.josat.2026.209997_bb0105","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.josat.2026.209997_bb0110","author":"SAMHSA"},{"key":"10.1016\/j.josat.2026.209997_bb0115","series-title":"SAS Data Management Overview","author":"SAS Institute Inc.","year":"2016"},{"issue":"18","key":"10.1016\/j.josat.2026.209997_bb0120","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","article-title":"Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire","volume":"282","author":"Spitzer","year":"1999","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.josat.2026.209997_bb0125","first-page":"200","article-title":"Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?","volume":"63","author":"Srivastava","year":"2017","journal-title":"Canadian Family Physician"},{"key":"10.1016\/j.josat.2026.209997_bb0130","series-title":"Stata Statistical Software: Release 18","author":"StataCorp","year":"2023"},{"key":"10.1016\/j.josat.2026.209997_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.110911","article-title":"Methamphetamine use and utilization of medications for opioid use disorder among rural people who use drugs","volume":"250","author":"Tsui","year":"2023","journal-title":"Drug Alcohol Dependence"},{"issue":"11","key":"10.1016\/j.josat.2026.209997_bb0140","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.49012","article-title":"Collaborative care model for patients with opioid use disorder and mental illness","volume":"7","author":"Watkins","year":"2024","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2026.209997_bb0145","series-title":"The PTSD Checklist for DSM-5 (PCL-5)","author":"Weathers","year":"2013"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926001177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926001177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T11:26:41Z","timestamp":1781522801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875926001177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"alternative-id":["S2949875926001177"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2026.209997","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stimulant use and increased severity of opioid use disorder and mental illness in patients with co-occurring disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2026.209997","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209997"}}